Glenmede Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

Glenmede Trust’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,037	Closed	-$408K	–	1260
2023 Q2	$408K	Hold	2,037	–	–	﹤0.01%	891
2023 Q1	$408K	Buy	2,037 +2	+0.1%	+$401	﹤0.01%	896
2022 Q4	$484K	Sell	2,035 -16	-0.8%	-$3.8K	﹤0.01%	842
2022 Q3	$410K	Buy	2,051 +7	+0.3%	+$1.4K	﹤0.01%	861
2022 Q2	$298K	Buy	+2,044	New	+$298K	﹤0.01%	1006
2020 Q4	–	Sell	-190	Closed	-$27K	–	1227
2020 Q3	$27K	Buy	190 +7	+4%	+$995	﹤0.01%	1490
2020 Q2	$27K	Sell	183 -2	-1%	-$295	﹤0.01%	1482
2020 Q1	$21K	Hold	185	–	–	﹤0.01%	2068
2019 Q4	$21K	Hold	185	–	–	﹤0.01%	2068
2019 Q3	$14	Hold	185	–	–	﹤0.01%	2205
2019 Q2	$13	Hold	185	–	–	﹤0.01%	2250
2019 Q1	$17	Hold	185	–	–	﹤0.01%	2134
2018 Q4	$13	Buy	+185	New	+$13	﹤0.01%	2158
2018 Q3	–	Sell	-175	Closed	-$17K	–	1442
2018 Q2	$17K	Hold	175	–	–	﹤0.01%	1755
2018 Q1	$22K	Hold	175	–	–	﹤0.01%	1918
2017 Q4	$22K	Hold	175	–	–	﹤0.01%	1918
2017 Q3	$20K	Hold	175	–	–	﹤0.01%	1959
2017 Q2	$8K	Hold	175	–	–	﹤0.01%	2169
2017 Q1	$8K	Hold	175	–	–	﹤0.01%	2169
2016 Q4	$6K	Sell	175 -175	-50%	-$6K	﹤0.01%	2193
2016 Q3	$23K	Sell	350 -150	-30%	-$9.86K	﹤0.01%	1889
2016 Q2	$27K	Hold	500	–	–	﹤0.01%	1785
2016 Q1	$31K	Hold	500	–	–	﹤0.01%	1672
2015 Q4	$47K	Hold	500	–	–	﹤0.01%	1584
2015 Q3	$40K	Buy	+500	New	+$40K	﹤0.01%	1659
2015 Q2	–	Sell	-1,400	Closed	-$146K	–	2676
2015 Q1	$146K	Hold	1,400	–	–	﹤0.01%	1354
2014 Q4	$135K	Sell	1,400 -600	-30%	-$57.9K	﹤0.01%	1434
2014 Q3	$156K	Sell	2,000 -400	-17%	-$31.2K	﹤0.01%	1265
2014 Q2	$151K	Hold	2,400	–	–	﹤0.01%	1267
2014 Q1	$161K	Sell	2,400 -300	-11%	-$20.1K	﹤0.01%	1247
2013 Q4	$173K	Sell	2,700 -300	-10%	-$19.2K	﹤0.01%	1199
2013 Q3	$192K	Sell	3,000 -350	-10%	-$22.4K	﹤0.01%	1145
2013 Q2	$103K	Buy	+3,350	New	+$103K	﹤0.01%	1303